Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM161BP1 is a pseudogene related to the transmembrane protein 161B gene. Pseudogenes do not code for functional proteins and are generally considered non-coding genomic loci. There is no evidence suggesting TMEM161BP1 is a therapeutic target, receptor, enzyme, or transporter, nor is it associated with any known biological function, drug interaction, molecular mechanism of action, or role in disease. Pseudogenes are often annotated due to sequence similarity to functional proteins, but they typically lack protein-coding potential or appreciable biological function. While some pseudogenes can play roles in gene regulation or disease when transcribed, there is no publicly available evidence linking TMEM161BP1 to such a function or to any drug or disease application. If you are seeking information on functional TMEM (Transmembrane protein) family members or the related protein-coding gene TMEM161B, please clarify. TMEM161BP1 itself is not an established molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 161B pseudogene 1 (TMEM161BP1).